{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:05:00Z","timestamp":1792443900872,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CSA-SI\/0005\/2021"],"award-info":[{"award-number":["CSA-SI\/0005\/2021"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CIRG23Jul-0036"],"award-info":[{"award-number":["CIRG23Jul-0036"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jinf.2024.106238","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T01:47:25Z","timestamp":1723081645000},"page":"106238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals"],"prefix":"10.1016","volume":"89","author":[{"given":"Amy May Lin","family":"Quek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ooiean","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8605-3810","authenticated-orcid":false,"given":"Bhuvaneshwari","family":"Shunmuganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette Guek Cheng","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Fa'izah Binte","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Xue Qi","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Siang Ling","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki YJ","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6640-1144","authenticated-orcid":false,"given":"Kiren","family":"Purushotorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hock Luen","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay Wei Ping","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1397-2135","authenticated-orcid":false,"given":"Yihui","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek Tuck Loong","family":"Soon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen Hee","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gim Gee","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha Suyien","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanda Leo","family":"Hartono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"MacAry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Chee Seong","family":"Seet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2024.106238_bib1","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2666-5247(20)30172-5","article-title":"SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis","volume":"2","author":"Cevik","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jinf.2024.106238_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0098-2022","article-title":"Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe","volume":"31","author":"Vardavas","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jinf.2024.106238_bib3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2024.106238_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jinf.2024.106238_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106238_bib6","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106238_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa2117608","article-title":"Final analysis of efficacy and safety of single-dose Ad26.COV2.S","volume":"386","author":"Sadoff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106238_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijid.2020.10.091","article-title":"The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects","volume":"102","author":"Al-Qahtani","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jinf.2024.106238_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262169","article-title":"SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection","volume":"17","author":"Havervall","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2024.106238_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2024.106238_bib11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijid.2021.04.035","article-title":"Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial","volume":"106","author":"Seet","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jinf.2024.106238_bib12","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1080\/07853890.2022.2108132","article-title":"Stable thyroid function despite regular use of povidone-iodine throat spray for SARS-CoV-2 prophylaxis","volume":"54","author":"Quek","year":"2022","journal-title":"Ann Med"},{"key":"10.1016\/j.jinf.2024.106238_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.731","article-title":"Zinc and vitamin C intake increases spike and neutralising antibody production following SARS-CoV-2 infection","volume":"12","author":"Quek","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jinf.2024.106238_bib14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cmi.2023.12.024","article-title":"Biomarkers of early SARS-CoV-2 infection prior to the onset of respiratory symptoms","volume":"30","author":"Teng","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2024.106238_bib15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2024.106238_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49231-w","article-title":"Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2","volume":"13","author":"Gu","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2024.106238_bib17","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/s41467-021-22767-z","article-title":"Next generation plasma proteome profiling to monitor health and disease","volume":"12","author":"Zhong","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jinf.2024.106238_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jinf.2024.106238_bib19","first-page":"405","article-title":"Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone","volume":"97","author":"Haneda","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2024.106238_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/096120330501400102","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.jinf.2024.106238_bib21","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jinf.2024.106238_bib22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00296-021-04910-7","article-title":"Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly","volume":"41","author":"Seyahi","year":"2021","journal-title":"Rheuma Int"},{"key":"10.1016\/j.jinf.2024.106238_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2004.02.006","article-title":"CXC chemokines: the regulatory link between inflammation and angiogenesis","volume":"25","author":"Romagnani","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jinf.2024.106238_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2013a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jinf.2024.106238_bib25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1172\/JCI11517","article-title":"Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses","volume":"107","author":"Fraticelli","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jinf.2024.106238_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mi.10.5.3","article-title":"Fractalkine\/CX3CL1: a potential new target for inflammatory diseases","volume":"10","author":"Jones","year":"2010","journal-title":"Mol Inter"},{"key":"10.1016\/j.jinf.2024.106238_bib27","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","article-title":"Metabolic Messengers: tumour necrosis factor","volume":"3","author":"Sethi","year":"2021","journal-title":"Nat Metab"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324001725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324001725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:59:39Z","timestamp":1778669979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324001725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0163445324001725"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106238","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106238"}}